The EULAR Sjögren's syndrome patient reported index as an independent determinant of health-related quality of life in primary sjögren's syndrome patients: In comparison with non-Sjögren's sicca patients

Rheumatology (United Kingdom)

Volumn 52, Issue 12, 2013, Pages 2208-2217

  Cho, Hyon Joung ^a   Yoo, Jong Jin ^b   Yun, Chan Young ^c   Kang, Eun Ha ^a   Lee, Hyo Jung ^a   Hyon, Joon Young ^a   Song, Yeong Wook ^d   Lee, Yun Jong ^a,d  

^a Seoul National University Bundang Hospital   (South Korea)

^b Armed Forces Capital Hospital   (South Korea)

^c Seonam Medical School   (South Korea)

^d Seoul National University College of Medicine   (South Korea)

Author keywords

Depression; EULAR Sj gren's syndrome patient reported index; Health related quality of life; Primary Sj gren's syndrome

Indexed keywords

ADULT; ANXIETY; ARTICLE; BURNING MOUTH SYNDROME; CLINICAL ASSESSMENT TOOL; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DRUG INDUCED DISEASE; DRUG INDUCED SICCA; DRY EYE; EULAR SJOGREN SYNDROME PATIENT REPORTED INDEX; FEMALE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MENTAL CAPACITY; PHYSICAL CAPACITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; SELF EVALUATION; SHORT FORM 36; SJOEGREN SYNDROME; UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE; XEROSTOMIA INVENTORY SCORE; ANALYSIS OF VARIANCE; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; FATIGUE; HEALTH STATUS INDICATOR; MIDDLE AGED; MYALGIA; PSYCHOLOGY; SOUTH KOREA; XEROSTOMIA;

ANALYSIS OF VARIANCE; ANXIETY; CROSS-SECTIONAL STUDIES; DEPRESSION; DRY EYE SYNDROMES; FATIGUE; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MIDDLE AGED; MYALGIA; PROSPECTIVE STUDIES; QUALITY OF LIFE; REPUBLIC OF KOREA; SJOGREN'S SYNDROME; XEROSTOMIA;

EID: 84891694355     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket270     Document Type: Article

References (44)

1. Mavragani CP, Moutsopoulos NM, Moutsopoulos HM. The management of Sjögren's syndrome. Nat Clin Pract Rheumatol 2006;2:252-61.
2. Tzioufas AG, Vlachoyiannopoulos PG. Sjogren's syndrome: an update on clinical, basic and diagnostic therapeutic aspects. J Autoimmun 2012;39:1-3.
3. Seror R, Bootsma H, Bowman SJ et al. Outcome measures for primary Sjögren's syndrome. J Autoimmun 2012;39:97-102.
4. Strömbeck B, Ekdahl C, Manthorpe R et al. Health-related quality of life in primary Sjögren's syndrome, rheumatoid arthritis and fibromyalgia compared to normal population data using SF-36. Scand J Rheumatol 2000;29:20-8.
5. Segal B, Bowman SJ, Fox PC et al. Primary Sjögren's syndrome:health experiences and predictors of health quality among patients in the United States. Health Qual Life Outcomes 2009;7:46.
6. Meijer JM, Meiners PM, Huddleston Slater JJ et al. Healthrelated quality of life, employment and disability in patients with Sjogren's syndrome. Rheumatology 2009;48:1077-82.
7. Hackett KL, Newton JL, Frith J et al. Impaired functional status in primary Sjögren's syndrome. Arthritis Care Res 2012;64:1760-4.
8. Bowman SJ, Booth DA, Platts RG. UK Sjögren's Interest Group. Measurement of fatigue and discomfort in primary Sjögren's syndrome using a new questionnaire tool. Rheumatology 2004;43:758-64.
9. Inal V, Kitapcioglu G, Karabulut G et al. Evaluation of quality of life in relation to anxiety and depression in primary Sjögren's syndrome. Mod Rheumatol 2010;20:588-97.
10. Enger TB, Palm.Ø, Garen T et al. Oral distress in primary Sjögren's syndrome:implications for health-related quality of life. Eur J Oral Sci 2011;119:474-80.
11. Kamel UF, Maddison P, Whitaker R. Impact of primary Sjogren's syndrome on smell and taste:effect on quality of life. Rheumatology 2009;48:1512-4.
12. McMillan AS, Leung KC, Leung WK et al. Impact of Sjögren's syndrome on oral health-related quality of life in southern Chinese. J Oral Rehabil 2004;31:653-9.
13. Kuyken W, Orley J, Hudelson P et al. Quality of life assessment across cultures. Int J Ment Health 1994;23:5-27.
14. Rostron J, Rogers S, Longman L et al. Health-related quality of life in patients with primary Sjögren's syndrome and xerostomia:a comparative study. Gerodontology 2002;19:53-9.
15. Champey J, Corruble E, Gottenberg JE et al. Quality of life and psychological status in patients with primary Sjögren's syndrome and sicca symptoms without autoimmune features. Arthritis Rheum 2006;55:451-7.
16. Seror R, Ravaud P, Mariette X et al. EULAR Sjogren's syndrome patient reported index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome. Ann Rheum Dis 2011;70:968-72.
17. Price EJ, Venables PJ. Dry eyes and mouth syndrome-a subgroup of patients presenting with sicca symptoms. Rheumatology 2002;41:416-22.
18. Mariette X, Caudmont C, Berge E et al. Dry eyes and mouth syndrome or sicca, asthenia and polyalgia syndrome? Rheumatology 2003;42:914-5.
19. Vitali C, Bombardieri S, Jonsson R et al. Classification criteria for Sjögren's syndrome:a revised version of the European criteria proposed by the American- European Consensus Group. Ann Rheum Dis 2002;61:554-8.
20. Choi HJ, Lee EO. The relationship between bathing and health status [in Korean]. J Korean Acad Nurs 2002;32:519-28.
21. Son YJ. The influencing factors on health related quality of life (HRQOL) in married working women [in Korean]. J Korean Acad Adult Nurs 2007;19:422-35.
22. Thomson WM, Williams SM. Further testing of the xerostomia inventory. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;89:46-50.
23. Ware JE Jr. SF-36 health survey update. Spine 2000;25:3130-9.
24. World Health Organization. Oral health survey:basic methods. 3rd edn. Geneva:World Health Organization, 1987.
25. Seror R, Ravaud P, Bowman SJ et al. EULAR Sjogren's syndrome disease activity index:development of a consensus systemic disease activity index for primary Sjogren's syndrome. Ann Rheum Dis 2010;69:1103-9.
26. Vitali C, Palombi G, Baldini C et al. Sjögren's syndrome disease damage index and disease activity index:scoring systems for the assessment of disease damage and disease activity in Sjögren's syndrome, derived from an analysis of a cohort of Italian patients. Arthritis Rheum 2007;56:2223-31.
27. Valtýsdóttir ST, Gudbjörnsson B, Lindqvist U et al. Anxiety and depression in patients with primary Sjögren's syndrome. J Rheumatol 2000;27:165-9.
28. Stevenson HA, Jones ME, Rostron JL et al. UK patients with primary Sjögren's syndrome are at increased risk from clinical depression. Gerodontology 2004;21:141-5.
29. Kang JH, Lin HC. Comorbidities in patients with primary Sjogren's syndrome:a registry-based case-control study. J Rheumatol 2010;37:1188-94.
30. Ramos-Casals M, Brito-Zerón P, Sisó-Almirall A et al. Topical and systemic medications for the treatment of primary Sjögren's syndrome. Nat Rev Rheumatol 2012;8:399-411.
31. Rayner L, Price A, Evans A et al. Antidepressants for depression in physically ill people. Cochrane Database Syst Rev 2010;3:CD007503.
32. Simmons DD, Al-Hashimi I, Haghighat N. Effect of xerostomic medications on stimulated salivary flow rate in patients with Sjögren's syndrome. Quintessence Int 2000;31:196-200.
33. Barendregt PJ, Visser MR, Smets EM et al. Fatigue in primary Sjögren's syndrome. Ann Rheum Dis 1998;57:291-5.
34. Strömbeck B, Theander E, Jacobsson LT. Assessment of fatigue in primary Sjögren's syndrome:the Swedish version of the Profile of Fatigue. Scand J Rheumatol 2005;34:455-9.
35. Segal B, Thomas W, Rogers T et al. Prevalence, severity, and predictors of fatigue in subjects with primary Sjögren's syndrome. Arthritis Rheum 2008;59:1780-7.
36. Barendregt PJ, Visser MR, Smets EM et al. Fatigue in primary Sjögren's syndrome. Ann Rheum Dis 1998;57:291-5.
37. Bax HI, Vriesendorp TM, Kallenberg CG et al. Fatigue and immune activity in Sjögren's syndrome. Ann Rheum Dis 2002;61:284.
38. Ng WF, Bowman SJ. Primary Sjogren's syndrome:too dry and too tired. Rheumatology 2010;49:844-53.
39. Dass S, Bowman SJ, Vital EM et al. Reduction of fatigue in Sjögren syndrome with rituximab:results of a randomised, double-blind, placebo-controlled pilot study. Ann Rheum Dis 2008;67:1541-4.
40. Meijer JM, Meiners PM, Vissink A et al. Effectiveness of rituximab treatment in primary Sjögren's syndrome:a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2010;62:960-8.
41. Norheim KB, Harboe E, Gøransson LG et al. Interleukin-1 inhibition and fatigue in primary Sjögren's syndrome-a double blind, randomised clinical trial. PLoS One 2012, Advance Access published 10 January 2012, doi:10.1371/journal.pone.0030123.
42. Strömbeck BE, Theander E, Jacobsson LT. Effects of exercise on aerobic capacity and fatigue in women with primary Sjogren's syndrome. Rheumatology 2007;46:868-71.
43. Campar A, Isenberg DA. Primary Sjögren's syndrome activity and damage indices comparison. Eur J Clin Invest 2010;40:636-44.
44. Risselada AP, Kruize AA, Bijlsma JW. Clinical applicability of the EULAR Sjogren's syndrome disease activity index:a cumulative ESSDAI score adds in describing disease severity. Ann Rheum Dis 2012;71:631.